Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage

Vaccine

Volumn 33, Issue 17, 2015, Pages 2045-2049

  Iqbal, Shahed ^a   Li, Rongxia ^a   Gargiullo, Paul ^b   Vellozzi, Claudia ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Epidemiology; Guillain Barr syndrome; Influenza; Influenza vaccine; Vaccine safety; Vaccines

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; FEMALE; FLU LIKE SYNDROME; GUILLAIN BARRE SYNDROME; HOSPITALIZATION; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; SEASONAL INFLUENZA; SEASONAL VARIATION; UNITED STATES; ADOLESCENT; AGED; COMPLICATION; GUILLAIN-BARRE SYNDROME; INFLUENZA, HUMAN; MIDDLE AGED; RISK; SEASON; STATISTICS AND NUMERICAL DATA; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; GUILLAIN-BARRE SYNDROME; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; RISK; SEASONS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84925940799     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.02.064     Document Type: Article

References (44)

1. Yuki N. Hartung H.P. Guillain-Barré syndrome. N Engl J Med 2012, 366(24):2294-2304.
2. Hughes R.A.C. Cornblath D.R. Guillain-Barré syndrome. Lancet 2005, 366:1653-1666.
3. Sejvar J.J. Baughman A.L. Wise M. Morgan O.W. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011, 36(2):123-133.
4. Shui I.M. Rett M.D. Weintraub E. et al. Guillain-Barré syndrome incidence in a large United States cohort (2000-2009). Neuroepidemiology 2012, 39(2):109-115.
5. Lehmann H.C. Hartung H.P. Kieseier B.C. Hughes R.A.C. Guillain-Barré syndrome after exposure to influenza virus. Lancet Infect Dis 2010, 10(9):643-651.
6. Stowe J. Andrews N. Wise L. Miller E. Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenza like illness using the United Kingdom general practice research database. Am J Epidemiol 2009, 169(3):382-388.
7. Tam C.C. O'Brien S.J. Petersen I. Islam A. Hayward A. Rodrigues L.C. Guillain-Barré syndrome and preceding infection with Campylobacter, Influenza and Epstein-Barr virus in the general practice research database. PLoS ONE 2007, 2(4):e344.
8. Tam C.C. O'Brien S.J. Rodrigues L.C. Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barré syndrome, England. Emerg Infect Dis 2006, 12(12):1880-1887.
9. Tam C.C. Rodrigues L.C. O'Brien S.J. Guillain-Barré syndrome associated with Campylobacter jejuni infection in England, 2000-2001. Clin Infect Dis 2003, 37(2):307-310.
10. Schonberger L.B. Bregman D.J. Sullivan-Bolyai J.Z. et al. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979, 110(2):105-123.
11. Hurwitz E.S. Schonberger L.B. Nelson D.B. Holman R.C. Guillain-Barré syndrome and the 1978-1979 influenza vaccine. N Engl J Med 1981, 304:1557-1561.
12. Kaplan J.E. Katona P. Hurwitz E.S. Schonberger L.B. Guillain-Barré syndrome in the United States, 1979-80 and 1980-81-lack of an association with influenza vaccination. JAMA 1982, 248:698-700.
13. Roscelli J.D. bass J.W. Pang L. Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-88. Am J Epidemiol 1991, 133:952-955.
14. Lasky T. Terracciano G.J. Magder L. Coski C.L. Ballesteros M. Nash D. et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998, 339(25):1797-1802.
15. Juurlink D.N. Stukel T.A. Kwong J. Kopp A. McGeer A. Upshur R.E. et al. Guillain-Barré syndrome after influenza vaccination in adults-a population-based study. Arch Intern Med 2006, 166(20):2217-2221.
16. Baxter R. Bakshi N. Fireman B. Lewis E. Ray P. Vellozzi C. et al. Lack of association of Guillain-Barré syndrome with vaccinations. Clin Infect Dis 2013, 57(2):197-204.
17. Burwen D.L. Ball R. Bryan W.W. Izurieta H.S. Voie L.L. Gibbs N.A. et al. Evaluation of Guillain-Barré syndrome among recipients of influenza vaccine in 2000 and 2001. Am J Prev Med 2010, 39(4):296-304.
18. Salmon D.A. Akhtar A. Mergler M.J. Vannice K.S. Isurieta H. Ball R. et al. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics 2011, 127:S78-S86.
19. Greene S.K. Rett M. Weintraub E.S. Li L. Yin R. Amato A.A. et al. Risk of confirmed Guillain-Barré syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Am J Epidemiol 2012, 175(11):1100-1109.
20. Tokars J.I. Lewis P. DeStefano F. Wise M. Viray M. Morgan O. et al. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses. Pharmacoepidemiol Drug Saf 2012, 21(5):546-552.
21. Wise M.E. Viray M. Sejvar J.J. Lewis P. Baughman A.L. Connor W. et al. Guillain-Barré syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol 2012, 175(11):1110-1119.
22. De Wals P. Deceuninck G. Toth E. Boulianne N. Brunet D. Boucher R.M. et al. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec. JAMA 2012, 308(2):175-181.
23. Polakowski L.L. Sandhu S.K. Martin D.B. Ball R. Macurdy T.E. Franks R.L. et al. Chart-confirmed Guillain-Barré syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010. Am J Epidemiol 2013, 178(6):962-973.
24. Huang W.T. Yang H.W. Liao T.L. Wu W.J. Yang S.E. Chih Y.C. et al. Safety of pandemic (H1N1) 2009 monovalent vaccines in Taiwan: a self-controlled case series study. PLoS ONE 2013, 8(3):e58827. 10.1371/journal.pone.0058827.
25. Salmon D.A. Proschan M. Forshee R. Gargiullo P. Bleser W. Burwen D.R. et al. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 2013, 381(9876):1461-1468. 27.
26. Dieleman J. Romio S. Johansen K. Weibel D. Bonhoeffer J. Sturkenboom M. VAESCO-GBS case-control study group, Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 2011, 343(Jul):d3908. 10.1136/bmj.d3908.
27. Greene S.K. Rett M.D. Vellozzi C. Li L. Kulldorff M. Marcy S.M. et al. Guillain-Barré syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the vaccine safety datalink, 2009-2011. PLoS ONE 2013, 8(6):e67185.
28. Grimaldi-Bensouda L. Alpérovitch A. Besson G. Vial C. Cuisset J.M. Papeix C. et al. For the GBS-PGRx study group, Guillain-Barré syndrome, influenza like illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol 2011, 174(3):326-335.
29. Vellozzi C. Iqbal S. Stewart B. Tokars J. Destefano F. Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic. Am J Public Health 2014, e1-e6. 10.2105/AJPH.2013.301651.
30. Verity C. Stellitano L. Winstone A.M. Stowe J. Andrews N. Miller E. Pandemic A/H1N1 2009 influenza vaccination preceding infections and clinical findings in UK children with Guillain-Barré syndrome. Arch Dis Child 2014, 99(6):532-538.
31. Sivadon-Tardy V. Orlikowski D. Porcher R. Sharshar T. Durand M.C. Enouf V. et al. Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis 2009, 48(1):48-56.
32. McGrogan A. Madle G.C. Seaman H.E. de Vries C.S. The epidemiology of Guillain-Barré syndrome worldwide. Neuroepidemiology 2009, 32:150-163.
33. Hughes R.A.C. Rees J.H. Clinical and epidemiological features of Guillain-Barré syndrome. J Infect Dis 1997, 176(Suppl. 2):S92-S98.
34. HCUP Nationwide Inpatient Sample (NIS) Healthcare cost and utilization project (HCUP) 2000-2010, Agency for Healthcare Research and Quality, Rockville, MD, 〈www.hcup-us.ahrq.gov/nisoverview.jsp〉 (accessed August 2012).
35. Agency for Healthcare Research and Quality (AHRQ). Healthcare Cost and Utilization Project (HCUP). Available at 〈http://www.ahrq.gov/data/hcup/#hcup〉 (accessed July 2010).
36. Agency for Healthcare Research and Quality (AHRQ). Introduction to the HCUP Nationwide Inpatient Sample (NIS) 2011. Available at 〈http://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2011.pdf〉 (accessed February 28, 2014).
37. Barrett M, Hickey K, Coffey R, Levit K. Population Denominator Data for use with the HCUP Databases (Updated with 2010 Population data). Online April 18, 2012. U.S. Agency for Healthcare Research and Quality. Available at: 〈http://www.hcupus.ahrq.gov/reports/methods/methods.jsp〉(accessed August 2012).
38. Vellozzi C. Iqbal S. Broder K. Guillain-Barré syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis 2014, 58(8):1149-1155.
39. Shimabukuro T.T. Wortley P.M. Bardenheier B. Bresnitz E.A. DeBlois A.M. Hahn C.G. et al. Survey of state practices during the 2004-2005 influenza vaccine shortage. Public Health Rep 2007, 122:311-318.
40. CDC Incidence of foodborne illness 2010, CDC, 〈Available at: http://www.cdc.gov/Features/dsFoodborneIllness/〉 (accessed September 29, 2014).
41. Jones T.F. McMillian M. Botthe E. Hanna S. Ingram L.A. Hospital discharge data for Guillain-Barré syndrome and influenza A (H1N1) vaccine adverse events. Emerg Infect Dis 2010, 16:1500-1501.
42. Grand' Maison F. Feasby T.E. Hahn A.F. et al. Recurrent Guillain-Barré syndrome. Clinical and laboratory features. Brain 1992, 115:1093-1106.
43. Das A. Kalita J. Misra U.K. Recurrent Guillain-Barré syndrome. Electromyogr Clin Neurophysiol 2004, 44:95-102.
44. CDC Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP) United States, 2014-15 influenza season. Morb Mort Wkly Rep 2014, 63(32):691-697.